| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Dec 3, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 37.5 | -3,333 | -3.77% | ✓ | $109.9K |
| Nov 14, 2025 | Nov 14, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 37.5 | -3,333 | -3.77% | ✓ | $100K |
| Oct 28, 2025 | Oct 30, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 17.5 | -16,665 | -16.87% | ✓ | $501K |
| May 1, 2025 | May 2, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 37.5 | -3,333 | -3.90% | ✓ | $106.7K |
| Apr 21, 2025 | Apr 23, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 37.5 | -3,334 | -3.90% | ✓ | $100K |
| Mar 3, 2025 | Mar 5, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 37.5 | -3,334 | -3.90% | ✓ | $107.2K |
| Feb 3, 2025 | Feb 5, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 37.5 | -3,334 | -3.90% | ✓ | $141K |
| Jan 2, 2025 | Jan 3, 2025 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 92.5 | +4,666 | 6.02% | ✓ | $731.8K |
| Sep 27, 2024 | Sep 27, 2024 | Janux Therapeutics, Inc. | Chief Business Officer | Sell | 17.5 | -50,000 | -42.52% | ✗ | $2.3M |